US and Europe Cell and Gene Therapy Manufacturing Services Market Overview and Growth by 2030
US and Europe Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral Vectors and Non-Viral Vectors)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)], and Country
- Status : Published
- Report Code : TIPRE00029984
- Category : Life Sciences
- No. of Pages : 147
- Available Report Formats :
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Indication, Application, and End User, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Companies operating in the market are Thermo Fisher Scientific Inc, Merck KGaA, Charles River Laboratories International Inc, Lonza Group AG, WuXi AppTec Co Ltd, Catalent Inc, Takara Bio Inc, Nikon Corp, FUJIFILM Holdings Corp, National Resilience Inc, and Oxford BioMedica Plc.
US and Europe Cell and Gene Therapy Manufacturing Services market is segmented by region into Europe, and the Middle East & Africa. US is likely to continue its dominance in the US and Europe Cell and gene therapy manufacturing services market during 2022–2030. The US holds the largest share of the market and is expected to continue this trend during the forecast period.
Major factors driving the market growth includes increase in number of approvals of cell and gene therapies and increasing popularity of outsourcing cell and gene therapy manufacturing. Additionally, automation of cell and gene therapy manufacturing services are likely to emerge as significant future trends in the market during the forecast period.
US and Europe Cell and Gene Therapy Manufacturing Services market, based on type, is segmented into cell therapy and gene therapy. Cell therapy is segmented as autologous and allogenic. Further, gene therapy is bifurcated into viral vector and non-viral vector. The cell therapy segment held a larger market share in 2022. However, gene therapy segment is anticipated to register the highest CAGR during the forecast period (2022-2030).
Answer:- Cell & gene therapy (CGT) programs are rapidly advancing from research & development to clinical trials and commercial approval. Establishing a robust, repeatable, and sustainable process help accelerate development, avoiding manufacturing transfer-related delays. Additionally, cell and gene therapy comprises the next generation of life-enhancing and curative therapies. With therapies experiencing new approvals, the demand for skilled professionals in cell and gene therapy manufacturing services will rise.
Based on indication, the US and Europe cell and gene therapy manufacturing services market is divided into cancer, orthopedics, and others. The cancer segment held the largest share of the market in 2022 and same segment is expected to grow at the highest CAGR during the forecast period.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 US and Europe Cell and Gene Therapy Manufacturing Services Market – by Type
1.3.2 US and Europe Cell and Gene Therapy Manufacturing Services Market – by Indication
1.3.3 US and Europe Cell and Gene Therapy Manufacturing Services Market – by Application
1.3.4 US and Europe Cell and Gene Therapy Manufacturing Services Market – by End User
1.3.5 US and Europe Cell and Gene Therapy Manufacturing Services Market – by Country & Region
2. US and Europe Cell and Gene Therapy Manufacturing Services Market – Key Takeaways
3. Research Methodology
3.2 Coverage
3.3 Secondary Research
3.4 Primary Research
4. US and Europe Cell and Gene Therapy Manufacturing Services Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 US PEST Analysis
4.2.2 Europe PEST Analysis
4.3 Expert’s Opinion
5. US and Europe Cell and Gene Therapy Manufacturing Services Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Number of Approval of Cell and Gene Therapies
5.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
5.2 Market Restraints
5.2.1 High Cost of Cell and Gene Therapy Manufacturing
5.3 Market Opportunities
5.3.1 Strategic Initiatives by Companies
5.4 Future Trends
5.4.1 Automation of Cell and Gene Therapy Manufacturing Services
5.5 Impact Analysis
6. US and Europe Cell and Gene Therapy Manufacturing Services Market – Country & Regional Analysis
6.1 US and Europe Cell and Gene Therapy Manufacturing Services Market Revenue Forecast and Analysis
6.2 Market Positioning of Key Players
7. US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 – by Type
7.1 Overview
7.2 US and Europe Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Type 2022 & 2030 (%)
7.3 Cell Therapy
7.3.1 Overview
7.3.2 Cell Therapy: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 Autologous
7.3.2.1.1 Overview
7.3.2.1.2 Autologous: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.2 Allogenic
7.3.2.2.1 Overview
7.3.2.2.2 Allogenic: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Gene Therapy
7.4.1 Overview
7.4.2 Gene Therapy: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 Viral Vector
7.4.2.1.1 Overview
7.4.2.1.2 Viral Vector: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.4.2.2 Non-Viral Vector
7.4.2.2.1 Overview
7.4.2.2.2 Non-Viral Vector: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
8. US and Europe Cell and Gene Therapy Manufacturing Services Market Analysis and Forecasts to 2030 – by Indication
8.1 Overview
8.2 US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication 2022 & 2030 (%)
8.3 Cancer
8.3.1 Overview
8.3.2 Cancer: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Orthopedics
8.4.1 Overview
8.4.2 Orthopedics: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
9. US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 – by Application
9.1 Overview
9.2 US and Europe Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Application 2022 & 2030 (%)
9.4 Clinical Manufacturing
9.4.1 Overview
9.4.2 Clinical Manufacturing: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Commercial Manufacturing
9.5.1 Overview
9.5.2 Commercial Manufacturing: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
10. US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 – by End User
10.1 Overview
10.2 US and Europe Cell and Gene Therapy Manufacturing Services Market Revenue Share, by End User 2022 & 2030 (%)
10.4 Pharmaceutical and Biotechnology Companies
10.4.1 Overview
10.4.2 Pharmaceutical & Biotechnology Companies: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Contract Research Organizations (CROs)
10.5.1 Overview
10.5.2 Contract Research Organizations (CROs): US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11. US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 – Country & Regional Analysis
11.1 US: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1 Overview
11.1.2 US: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.1.2.1 US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.1.2.1.1 US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.1.2.1.2 US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.1.2.2 US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.1.2.3 US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.1.2.4 US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.2 Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market
11.2.1 Overview
11.2.2 Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3 Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.2.3.1 Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.2.3.2 Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.2.4 Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.2.5 Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.2.6 Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.2.7 Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Country, 2022 & 2030 (%)
11.2.7.1 Germany: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.1.1 Overview
11.2.7.1.2 Germany: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.1.3 Germany: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.2.7.1.3.1 Germany: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.2.7.1.3.2 Germany: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.2.7.1.4 Germany: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.2.7.1.5 Germany: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.2.7.1.6 Germany: US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.2.7.2 UK: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.2.1 Overview
11.2.7.2.2 UK: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.2.3 UK: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.2.7.2.3.1 UK: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.2.7.2.3.2 UK: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.2.7.2.4 UK: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.2.7.2.5 UK: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.2.7.2.6 UK: US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.2.7.3 France: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.3.1 Overview
11.2.7.3.2 France: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.3.3 France: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.2.7.3.3.1 France: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.2.7.3.3.2 France: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.2.7.3.4 France: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.2.7.3.5 France: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.2.7.3.6 France: US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.2.7.4 Italy: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.4.1 Overview
11.2.7.4.2 Italy: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.4.3 Italy: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.2.7.4.3.1 Italy: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.2.7.4.3.2 Italy: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.2.7.4.4 Italy: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.2.7.4.5 Italy: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.2.7.4.6 Italy: US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.2.7.5 Spain: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.5.1 Overview
11.2.7.5.2 Spain: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.5.3 Spain: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.2.7.5.3.1 Spain: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.2.7.5.3.2 Spain: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.2.7.5.4 Spain: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.2.7.5.5 Spain: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.2.7.5.6 Spain: US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.2.7.6 Rest of Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.6.3 Rest of Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.2.7.6.3.1 Rest of Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.2.7.6.3.2 Rest of Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.2.7.6.4 Rest of Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.2.7.6.5 Italy: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.2.7.6.6 Rest of Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
12. US and Europe Cell and Gene Therapy Manufacturing Services Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies in US and Europe Cell and Gene Therapy Manufacturing Services Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Thermo Fisher Scientific Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Merck KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Charles River Laboratories InternationalInc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Lonza Group AG
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 WuXi AppTec Co Ltd?
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Catalent Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Takara Bio Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Nikon Corp
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 FUJIFILM Holdings Corp
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 National Resilience Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Oxford BioMedica Plc
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
List of Tables
Table 1. US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 2. US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy – Revenue and Forecast to 2030 (US$ Million)
Table 3. US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy – Revenue and Forecast to 2030 (US$ Million)
Table 4. US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication – Revenue and Forecast to 2030 (US$ Million)
Table 5. US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 6. US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 7. Europe US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 8. Europe US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy – Revenue and Forecast to 2030 (US$ Million)
Table 9. Europe US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy – Revenue and Forecast to 2030 (US$ Million)
Table 10. Europe US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication – Revenue and Forecast to 2030 (US$ Million)
Table 11. Europe US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 12. Europe US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 13. Germany US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 14. Germany US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy – Revenue and Forecast to 2030 (US$ Million)
Table 15. Germany US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy – Revenue and Forecast to 2030 (US$ Million)
Table 16. Germany US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication – Revenue and Forecast to 2030 (US$ Million)
Table 17. Germany US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 18. Germany US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 19. UK US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 20. UK US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy – Revenue and Forecast to 2030 (US$ Million)
Table 21. UK US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy – Revenue and Forecast to 2030 (US$ Million)
Table 22. UK US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication – Revenue and Forecast to 2030 (US$ Million)
Table 23. UK US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 24. UK US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 25. France US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 26. France US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy – Revenue and Forecast to 2030 (US$ Million)
Table 27. France US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy – Revenue and Forecast to 2030 (US$ Million)
Table 28. France US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication – Revenue and Forecast to 2030 (US$ Million)
Table 29. France US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 30. France US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 31. Italy US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 32. Italy US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy – Revenue and Forecast to 2030 (US$ Million)
Table 33. Italy US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy – Revenue and Forecast to 2030 (US$ Million)
Table 34. Italy US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication – Revenue and Forecast to 2030 (US$ Million)
Table 35. Italy US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 36. Italy US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 37. Spain US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 38. Spain US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy – Revenue and Forecast to 2030 (US$ Million)
Table 39. Spain US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy – Revenue and Forecast to 2030 (US$ Million)
Table 40. Spain US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication – Revenue and Forecast to 2030 (US$ Million)
Table 41. Spain US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 42. Spain US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 43. Rest of Europe US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 44. Rest of Europe US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy – Revenue and Forecast to 2030 (US$ Million)
Table 45. Rest of Europe US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy – Revenue and Forecast to 2030 (US$ Million)
Table 46. Rest of Europe US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication – Revenue and Forecast to 2030 (US$ Million)
Table 47. Italy US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 48. Rest of Europe US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 49. Recent Organic Growth Strategies in US and Europe Cell and Gene Therapy Manufacturing Services Market
Table 50. Recent Inorganic Growth Strategies in the US and Europe Cell and Gene Therapy Manufacturing Services Market
Table 51. Glossary of Terms
List of Figures
Figure 1. US and Europe Cell and Gene Therapy Manufacturing Services Market Segmentation
Figure 2. US and Europe Cell and Gene Therapy Manufacturing Services Market, by Region
Figure 3. US and Europe Cell and Gene Therapy Manufacturing Services Market Overview
Figure 4. Cell Therapy Segment Held Largest Share of Type Segment in US and Europe Cell and Gene Therapy Manufacturing Services Market
Figure 5. US and Europe Cell and Gene Therapy Manufacturing Services Market, by Country & Region (US$ Million)
Figure 6. US and Europe Cell and Gene Therapy Manufacturing Services Market – Leading Country Markets (US$ Million)
Figure 7. US and Europe Cell and Gene Therapy Manufacturing Services Market – Industry Landscape
Figure 8. US: PEST Analysis
Figure 9. Europe: PEST Analysis
Figure 10. Experts’ Opinion
Figure 11. US and Europe Cell and Gene Therapy Manufacturing Services Market: Key Industry Dynamics
Figure 12. US and Europe Cell and Gene Therapy Manufacturing Services Market: Impact Analysis of Drivers and Restraints
Figure 13. US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue Forecast and Analysis – 2021-2030
Figure 14. Market Positioning of Key Players in US and Europe Cell and Gene Therapy Manufacturing Services Market
Figure 15. US and Europe Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Type 2022 & 2030 (%)
Figure 16. Cell Therapy: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Autologous: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Allogenic: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Gene Therapy: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Viral Vector: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Non-Viral Vector: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application 2022 & 2030 (%)
Figure 23. Cancer: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Orthopedics: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Others: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. US and Europe Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Application 2022 & 2030 (%)
Figure 27. Clinical Manufacturing: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Commercial Manufacturing: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. US and Europe Cell and Gene Therapy Manufacturing Services Market Revenue Share, by End User 2022 & 2030 (%)
Figure 30. Pharmaceutical & Biotechnology Companies: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Contract Research Organizations (CROs): US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. United States: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Key Country – Revenue (2022) (US$ Million)
Figure 33. US: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 34. Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Key Country – Revenue (2022) (US$ Million)
Figure 35. Europe US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 36. Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Country, 2022 & 2030 (%)
Figure 37. Germany: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 38. UK: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 39. France: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 40. Italy: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 41. Spain: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 42. Rest of Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 43. Growth Strategies in US and Europe Cell and Gene Therapy Manufacturing Services Market
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For